i had a couple of replies with some major poster here before: research in such field wouldn't be made by big pharma, since antibiotics is their cash cow. in fact they lobby doctors to over prescribe antibiotics , hence the superbugs (which is a case in 1 million or something, not economically viable to develop a treatement for it. but they'r testing the limits: it wouldnt help if everyone is hosting mrsa either)